RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kent Nilsson, MD
Piedmont Athens Regional
Principal Investigator - Lucas Boersma, Prof. MD.
St. Antonius Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Olv Hospital Aalst
Aalst, Belgium
- Zna Middelheim
Antwerp, Belgium
- Zol
Genk, Belgium
- Neuron Medical
Brno, Czechia
- Ikem (institute for Clinical and Experimental Medicine)
Prague, Czechia
- Na Homolce Hospital
Prague, Czechia
- Amsterdam Umc (location Amc)
Amsterdam, North Holland, Netherlands
- St. Antonius Hospital
Nieuwegein, Utrecht, Netherlands
- Erasmus Mc
Rotterdam, Netherlands
- Grandview Medical Center
Birmingham, Alabama, United States
- University of Alabama
Birmingham, Alabama, United States
- Banner Health
Phoenix, Arizona, United States
- Sutter Health Sequoia Heart and Vascular Institute
Redwood City, California, United States
- Pacific Heart Institute
Santa Monica, California, United States
- Colorado Heart
Golden, Colorado, United States
- Florida Heart Rhythm Specialists
Fort Lauderdale, Florida, United States
- Ascension Medical Group
Jacksonville, Florida, United States
- Piedmont Health
Athens, Georgia, United States
- Beaumont Health
Royal Oak, Michigan, United States
- Mount Sinai Hospital
New York, New York, United States
- Ohio State University
Columbus, Ohio, United States
- University of Virginia
Charlottesville, Virginia, United States
- Inova Health
Falls Church, Virginia, United States
- Evergreen Health Research/overlake Medical Center
Bellevue, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Oct 2023
- Primary completion
- 31 Jan 2026
- Completion
- 31 Jan 2026
- Last update posted
- 13 Apr 2025
- Registered enrollment
- 400
- Registry id
- NCT05883631
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.